Suppr超能文献

前沿:Toll样受体(TLR)配体通过减缓肽-主要组织相容性复合体I类分子的降解速率来增强T细胞受体(TCR)的触发。

Cutting edge: TLR ligands increase TCR triggering by slowing peptide-MHC class I decay rates.

作者信息

Rudd Brian D, Brien James D, Davenport Miles P, Nikolich-Zugich Janko

机构信息

Department of Immunobiology and the Arizona Center on Aging, University of Arizona College of Medicine, Tucson, AZ 85718, USA.

出版信息

J Immunol. 2008 Oct 15;181(8):5199-203. doi: 10.4049/jimmunol.181.8.5199.

Abstract

TLR ligands are among the key stimuli driving the optimal dendritic cell (DC) maturation critical for strong and efficacious T cell priming. In this study, we show that part of this effect occurs via increased TCR triggering. Pretreatment of DCs with TLR ligands resulted in the triggering of many more TCRs in responding CD8(+) T cells. Importantly, even when DCs expressed the same amount of cognate peptide-MHC (pMHC) molecules, TLR ligand treatment resulted in down-regulation of larger numbers of TCR molecules. This was independent of the up-regulation of costimulatory, adhesion or cytokine molecules or the amount of noncognate pMHCs. Rather, DCs pretreated with TLR ligands exhibited increased stability of cognate pMHCs, enabling extended TCR triggering. These findings are of potential importance to T cell vaccination.

摘要

Toll样受体(TLR)配体是驱动树突状细胞(DC)最佳成熟的关键刺激因素之一,而DC的最佳成熟对于强大而有效的T细胞启动至关重要。在本研究中,我们表明这种效应部分是通过增加T细胞受体(TCR)触发而发生的。用TLR配体预处理DC会导致反应性CD8(+) T细胞中更多的TCR被触发。重要的是,即使DC表达相同数量的同源肽-主要组织相容性复合体(pMHC)分子,TLR配体处理也会导致更多数量的TCR分子下调。这与共刺激分子、黏附分子或细胞因子分子的上调或非同源pMHC的数量无关。相反,用TLR配体预处理的DC表现出同源pMHC稳定性增加,从而能够延长TCR触发。这些发现对T细胞疫苗接种具有潜在的重要意义。

相似文献

引用本文的文献

6
Characterizing the dynamics of CD4+ T cell priming within a lymph node.描述淋巴结内 CD4+ T 细胞初始激活的动力学。
J Immunol. 2010 Mar 15;184(6):2873-85. doi: 10.4049/jimmunol.0903117. Epub 2010 Feb 12.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验